Merrion Pharmaceuticals, the publicly quoted Irish pharma company, is seeking to raise $65 million from investors to fund a new breast cancer drug.
The company, which is traded on the small cap market in Dublin, is hoping to raise the money as soon as possible to fund clinical drug trials for a product it believes will drive it into the future.
Merrion is eyeing up either a new equity partner or a partnership deal on the...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
Then €19.99 a month after the offer period.
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team